Skip to main content

View full-text article in PMC

. 2019 Feb 6;11:13. doi: 10.1186/s13098-019-0410-5

Table 1.

General characteristics of study participants (x ± s)

	Control	DKA		NKH
	Control	Before treatment	After treatment	Before treatment	After treatment
No. cases (male/female)	30 (14/16)	32 (18/14)		31 (16/15)
Age (years)	49.85 ± 8.72	51.45 ± 11.96		50.63 ± 10.06
BMI (kg/m²)	25.87 ± 5.91	24.19 ± 7.83		24.99 ± 9.07
WHR	0.87 ± 0.09	0.86 ± 0.04		0.88 ± 0.10
Body temperature (°C)	36.20 ± 3.33	37.03 ± 6.89	36.95 ± 7.75	37.10 ± 7.12	36.84 ± 6.83
Systolic pressure (mmHg)	128 ± 18	126 ± 20	130 ± 18	126 ± 22	128 ± 16
Diastolic pressure (mmHg)	78 ± 9	76 ± 8	78 ± 12	76 ± 10	77 ± 11
White blood cell count (× 10⁶)	7.82 ± 1.16	16.94 ± 6.57^a	8.65 ± 4.28^b	14.93 ± 7.22^a	8.45 ± 6.58^b

DKA: diabetic ketoacidosis group; NKH: non-ketotic hyperglycemia group; control group: healthy individuals

^aP < 0.05, compared with controls

^bP < 0.05, compared with the same group before treatment